Thomas Gajewski, MD, PhDEnriched profile
AbbVie Foundation Professor of Pathology; Professor of Medicine; Professor, Ben May Department for Cancer Research; Leader, Immunology and Cancer Program, University of Chicago Comprehensive Cancer Center · University of Chicago
Overview
Updated 14 Jul 2026
Thomas F. Gajewski is AbbVie Foundation Professor of Pathology at University of Chicago. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 11 companies, 15 NIH-funded awards (1998–2026).
- Top research focus: Melanoma
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma
Sponsor: University of Chicago
InvestigatorPhase 2Active, not recruitingNCT02743819 - Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2TerminatedNCT01307618 - Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2CompletedNCT00669019
Industry payments
Updated 14 Jul 2026
11 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20241 payment
- Merck Sharp & Dohme LLCProgram year20241 payment
- ABBVIE INC.Program year20239 payments$14,818openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
15 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
5841 S. Maryland Ave., MC3083, Rm. S329, Chicago, IL 60637
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- MD
University of Chicago Pritzker School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗ - PhD in Immunology
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗ - AB/BS
University of Chicago
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.uchicago.edu ↗
Editorial & leadership rolesjournal and society appointments
- Immediate Past President
Society for Immunotherapy of Cancer (SITC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.uchicago.edu ↗ - Founding Editor
Journal for Immunotherapy of Cancer (JITC)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →brightpeaktx.com ↗ - Editor
Cancer Research (AACR journal)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uchicagomedicine.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerresearch.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →brightpeaktx.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →brightpeaktx.com ↗
Secondary affiliationsappointments beyond the home institution
- Committee on Cancer Biology
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerbio.uchicago.edu ↗ - Committee on Immunology
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →immunology.uchicago.edu ↗ - Director
Human Immunologic Monitoring core facility, University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.uchicago.edu ↗
Media & interviewspress, podcasts and appearances
- PBS "Great Conversations" (Season 20, Episode 7)
interview with Charles Graeber on cancer immunotherapy
- Moffitt Cancer Center "ImmunoVerse" podcast
"Hot vs. Cold Tumors: Decoding the Tumor Microenvironment"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →moffitt.org ↗ - CancerNetwork video interview
"Analyzing the Tumor Microenvironment to Guide Immunotherapy in Melanoma"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/thomas-gajewski-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/thomas-gajewski-40b00526
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
sitcancer.org/membership/academy-immuno-oncology/faio/gajewski-faio
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sitcancer.org ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/university-of-chicago-medicine-comprehensive-cancer-center_congrats-to-thomas-gajewski-md-phd-on-activity-7387163139366326272-qjaH
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/university-of-chicago-medicine_congratulations-to-thomas-gajewski-md-phd-activity-6608792015868084224-qEjj
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - X / Twitter
x.com/UCCancerCenter/status/1981412561527464374
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
- 1,236
- publications
- 120
- h-index
- 23
- trials
Mary Rinella, MD
University of Chicago
- 279
- publications
- 71
- h-index
- 4
- trials
Andrzej Jakubowiak, MD, PhD
University of Chicago
- 477
- publications
- 68
- h-index
- 11
- trials
Jay Koyner, MD
University of Chicago
- 478
- publications
- 58
- h-index
- 7
- trials